Zobrazeno 1 - 10
of 149
pro vyhledávání: '"clinical breakpoints"'
Autor:
Jinhan Yu, Chun He, Tong Wang, Ge Zhang, Jin Li, Jingjia Zhang, Wei Kang, Yingchun Xu, Ying Zhao
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
Fungal pathogens are a major threat to public health, as they are becoming increasingly common and resistant to treatment, with only four classes of antifungal medicines currently available and few candidates in the clinical development pipeline. Mos
Externí odkaz:
https://doaj.org/article/c5b57ed3d9dc456d80bfd59350b570d3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Fungi, Vol 9, Iss 3, p 306 (2023)
Providing timely antifungal treatment to patients suffering from life-threatening invasive fungal infections (IFIs) is essential. Due to the changing epidemiology and the emergence of antifungal resistance in Aspergillus, the most commonly responsibl
Externí odkaz:
https://doaj.org/article/4d9723d5d3e34d36b859be9fa8c5b7b6
Autor:
Muhammad Kashif Maan, Zhifei Weng, Menghong Dai, Zhenli Liu, Haihong Hao, Guyue Cheng, Yulian Wang, Xu Wang, Lingli Huang
Publikováno v:
Antibiotics, Vol 10, Iss 2, p 153 (2021)
Cyadox has potential use as an antimicrobial agent in animals. However, its pharmacodynamic properties have not been systematically studied yet. In this study, the in vitro antibacterial activities of cyadox were assayed, and the antibacterial effica
Externí odkaz:
https://doaj.org/article/8ec24439abce4f95b542d8b245476383
Autor:
Jesús Guinea
Publikováno v:
Journal of Fungi, Vol 6, Iss 4, p 343 (2020)
Azole resistance poses a problem for the management of patients with invasive aspergillosis. Former species are in fact groups of closely related species (or complexes); cryptic species frequently show high antifungal resistance. The European Committ
Externí odkaz:
https://doaj.org/article/e9ca91091a0e4ad3a196a5ba761b6f9e
Publikováno v:
Journal of Fungi, Vol 7, Iss 1, p 17 (2020)
Invasive fungal infections (IFIs) are associated with high mortality rates and timely appropriate antifungal therapy is essential for good outcomes. Emerging antifungal resistance among Candida and Aspergillus spp., the major causes of IFI, is concer
Externí odkaz:
https://doaj.org/article/e822c0ff0e7944de91c93d8ae938e708
Autor:
Cornelia Lass-Flörl, Robert Krause, Birgit Willinger, Peter Starzengruber, Petra Decristoforo, Sabrina Neururer, Peter Kreidl, Maria Aigner
Publikováno v:
Journal of Fungi, Vol 6, Iss 2, p 76 (2020)
This prospective noninterventional study evaluated whether antifungal susceptibility data (MIC) provided for Candida clinical isolates on the basis of recently established breakpoints are taken into account by clinicians to guide their treatment deci
Externí odkaz:
https://doaj.org/article/18922a42dc444f16aa494088ba4f8756
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N. S. Bagirova, N. V. Dmitrieva
Publikováno v:
Журнал инфектологии, Vol 7, Iss 3, Pp 91-102 (2015)
Evaluation of susceptibility of systemic antifungal agents against Candida spp. in recent years has been standardized and refined based on species-specific characteristics of Candida. In addition to new values clinical breakpoints were introduced epi
Externí odkaz:
https://doaj.org/article/fd6af490538544c1b042f0f2b5fe7a99